GSK has claimed US approval for Jemperli alongside chemotherapy for previously untreated, primary advanced or recurrent endometrial cancer, becoming the first immunotherapy option for first-line ...

GSK’s PD-1 inhibitor Jemperli has been cleared for use by the NHS as a first-line treatment for a specific type of endometrial cancer, making it an option for around 580 women across England ...

Cadonilimab plus lenvatinib showed promising antitumor activity in patients with advanced endometrial cancer who have experienced disease progression after prior platinum-based chemotherapy,” said ...

Schonfeld SJ, Hartge P, Pfeiffer, RM, et al. An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer 2012 Dec 20. doi: 10.1002/cncr.27909. [Epub ahead of print] It ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines through its powerful computational drug discovery engine, today ...

The middle-class income was then calculated using PewResearch’s definition of middle-class. Keep reading to see what the line looks like between middle-class and upper middle class-income.

Approximately 90% of patients diagnosed with endometrial cancer present with complaints of irregular or postmenopausal vaginal bleeding. However, this symptom is not specific and can also occur ...

The LINE Messaging API SDK for Java makes it easy to develop bots using LINE Messaging API, and you can create a sample bot within minutes. Note: You don't need to use an add-on like Fixie to have ...

Shares of Iovance Biotherapeutics have plummeted post-Amtagvi approval. Read more to see a full investment analysis for IOVA ...

For over 30 years, Life Line Screening has provided preventive health screenings for stroke and cardiovascular disease risk in community-based buildings. Its screenings are noninvasive ...

Endometriosis is not just a health issue—it is a career disruptor for women and the pain is often invisible but relentless.